Recently a start-up company was established to develop immunotherapy for the treatment of Alzheimer’s. This is the first time that a treatment approach based on activating the immune system will be tested, as opposed to treatment that is aimed directly at the brain. Prof. Schwartz has published more than 300 scientific articles in leading journals such as Nature, Science, Nature Medicine, Neuroscience, Nature Review, and the Journal of Clinical Investigation. For her notable contributions, she has received numerous awards and titles, including the Elkon Prize, an Honorary Doctorate from Ben-Gurion University of the Negev for scientific revolution and her contribution to the advancement of science, a Guest Honorary Doctorate at Manchester University, an honorary membership in the international Society for Immunotherapy and the Bloomberg Award for Excellence for her achievements in biomedicine.
Many of Prof. Schwartz’s students have completed doctorates under her mentorship as recipients of awards for excellence at the Weizmann Institute of Science for their scientific achievements, and they hold senior positions in academe and in industry in Israel and throughout the world.